CARM   $1.0  0.0 Market Closed After Close 1.03 3.00%

Carisma Therapeutics Inc
Total Cash 41.91M
totalCashPerShare 1.009
EBITDA -72.61M
Total Debt 3.76M
quickRatio 2.812
currentRatio 3.248
Total Revenue 20.71M
debtToEquity 1044.167
Revenue/Share 0.507
ROA -0.49372002
ROE -2.16211
grossProfits
freeCashflow -46.39M
operatingCashflow -75.64M
earningsGrowth
revenueGrowth 1.583
grossMargins -2.46379
ebitdaMargins 0.0
operatingMargins -1.26889
profitMargins 0.0
enterpriseValue 4.22M
forwardPE -0.80799997
floatShares 22.51M
sharesOutstanding 41.55M
sharesShort 1.10M
sharesShortPriorMonth 995.88K
dateShortInterest
sharesPercentSharesOut 0.03%
heldPercentInsiders 0.29%
heldPercentInstitutions 0.34%
Short Ratio help_outline 5.79%
shortPercentOfFloat 0.03%
impliedSharesOutstanding
bookValue 0.009
Price To Book help_outline 112.22
earningsQuarterlyGrowth
netIncomeToCommon -72.50M
trailingEps -1.65%
forwardEps -1.25%
enterpriseToEbitda -0.06
lastDividendValue
lastDividendDate
currentQuarterEstimate -0.28 3Q 2024
institutionsCount 70
lastUpdated Sept. 17, 2024, 2:47 a.m.